Substrate Recognition Mechanism of VAMP/Synaptobrevin-cleaving Clostridial Neurotoxins*

Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) inhibit neurotransmitter release by proteolyzing a single peptide bond in one of the three soluble N-ethylmaleimide-sensitive factor attachment protein receptors SNAP-25, syntaxin, and vesicle-associated membrane protein (VAMP)/synaptobrevin. TeNT and BoNT/B, D, F, and G of the seven known BoNTs cleave the synaptic vesicle protein VAMP/synaptobrevin. Except for BoNT/B and TeNT, they cleave unique peptide bonds, and prior work suggested that different substrate segments are required for the interaction of each toxin. Although the mode of SNAP-25 cleavage by BoNT/A and E has recently been studied in detail, the mechanism of VAMP/synaptobrevin proteolysis is fragmentary. Here, we report the determination of all substrate residues that are involved in the interaction with BoNT/B, D, and F and TeNT by means of systematic mutagenesis of VAMP/synaptobrevin. For each of the toxins, three or more residues clustered at an N-terminal site remote from the respective scissile bond are identified that affect solely substrate binding. These exosites exhibit different sizes and distances to the scissile peptide bonds for each neurotoxin. Substrate segments C-terminal of the cleavage site (P4-P4′) do not play a role in the catalytic process. Mutation of residues in the proximity of the scissile bond exclusively affects the turnover number; however, the importance of individual positions at the cleavage sites varied for each toxin. The data show that, similar to the SNAP-25 proteolyzing BoNT/A and E, VAMP/synaptobrevin-specific clostridial neurotoxins also initiate substrate interaction, employing an exosite located N-terminal of the scissile peptide bond.

[1]  James J. Schmidt,et al.  Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. , 2005, Biochemistry.

[2]  Axel T. Brunger,et al.  Substrate recognition strategy for botulinum neurotoxin serotype A , 2004, Nature.

[3]  Cesare Montecucco,et al.  The interaction of synaptic vesicle‐associated membrane protein/synaptobrevin with botulinum neurotoxins D and F , 1997, FEBS letters.

[4]  C. Montecucco,et al.  Structural Determinants of the Specificity for Synaptic Vesicle-associated Membrane Protein/Synaptobrevin of Tetanus and Botulinum Type B and G Neurotoxins* , 1996, The Journal of Biological Chemistry.

[5]  S. Swaminathan,et al.  Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B. , 2006, Journal of molecular biology.

[6]  K. Janda,et al.  Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. , 2006, Biochemistry.

[7]  T. Galli,et al.  The Tetanus Neurotoxin‐Sensitive and Insensitive Routes to and from the Plasma Membrane: Fast and Slow Pathways? , 2005, Traffic.

[8]  C. Shone,et al.  Analysis of the substrate recognition domain determinants of botulinum type B toxin using phage display. , 2005, Toxicon : official journal of the International Society on Toxinology.

[9]  S. Swaminathan,et al.  Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme. , 2005, Biochemistry.

[10]  T. Galli,et al.  A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells. , 1998, Molecular biology of the cell.

[11]  G. Schiavo,et al.  Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.

[12]  R. Wait,et al.  Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin. , 1993, European journal of biochemistry.

[13]  R. Scheller,et al.  Botulinum Neurotoxin Type C Cleaves a Single Lys-Ala Bond within the Carboxyl-terminal Region of Syntaxins (*) , 1995, The Journal of Biological Chemistry.

[14]  A. Brunger,et al.  Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity. , 2007, Biochemistry.

[15]  G. Schiavo,et al.  Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release. , 1994, Seminars in cell biology.

[16]  C Lenoir,et al.  Cooperative Exosite-dependent Cleavage of Synaptobrevin by Tetanus Toxin Light Chain* , 1997, The Journal of Biological Chemistry.

[17]  M. D'Esposito,et al.  Longins: a new evolutionary conserved VAMP family sharing a novel SNARE domain. , 2001, Trends in biochemical sciences.

[18]  Y. Humeau,et al.  How botulinum and tetanus neurotoxins block neurotransmitter release. , 2000, Biochimie.

[19]  Cesare Montecucco,et al.  Botulinum neurotoxin types A and E require the SNARE motif in SNAP‐25 for proteolysis , 1997, FEBS letters.

[20]  S. Nauenburg,et al.  Proteolysis of SNAP‐25 Isoforms by Botulinum Neurotoxin Types A, C, and E , 1999, Journal of neurochemistry.

[21]  T. Südhof,et al.  Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. , 1994, The Journal of biological chemistry.

[22]  J. Barbieri,et al.  Unique Substrate Recognition by Botulinum Neurotoxins Serotypes A and E* , 2006, Journal of Biological Chemistry.

[23]  J. Barbieri,et al.  Multiple Pocket Recognition of SNAP25 by Botulinum Neurotoxin Serotype E* , 2007, Journal of Biological Chemistry.

[24]  R. Jahn,et al.  Clostridial neurotoxins: new tools for dissecting exocytosis. , 1994, Trends in cell biology.

[25]  Mark K. Bennett,et al.  A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion , 1993, Cell.

[26]  J. Barbieri,et al.  Mechanism of Substrate Recognition by Botulinum Neurotoxin Serotype A* , 2007, Journal of Biological Chemistry.

[27]  R. Scheller,et al.  Seven Novel Mammalian SNARE Proteins Localize to Distinct Membrane Compartments* , 1998, The Journal of Biological Chemistry.

[28]  J. Dolly,et al.  Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. , 1994, Biochemistry.

[29]  C. Montecucco,et al.  Substrate residues N‐terminal to the cleavage site of botulinum type B neurotoxin play a role in determining the specificity of its endopeptidase activity , 1996, FEBS letters.